Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer.
| Autor: | Baselga J, Segalla JG, Roché H, Del Giglio A, Pinczowski H, Ciruelos EM, Filho SC, Gómez P, Van Eyll B, Bermejo B, Llombart A, Garicochea B, Durán MA, Hoff PM, Espié M, de Moraes AA, Ribeiro RA, Mathias C, Gil Gil M, Ojeda B |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 5/1/2012, Vol. 30 Issue 13, p1484-1491, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|